Last updated on July 2019

A Multicenter Feasibility Study of DyeVert Plus™ Contrast Reduction System Use to Reduce Contrast Media Volumes in Angiography Procedures Using Optical Coherence Tomography Dyevert


Brief description of study

The purpose of this post-market feasibility study is to evaluate whether DyeVert Plus Contrast Reduction System use during standard angiography procedures involving the use of OCT result in contrast media (CM) volume savings without reducing image quality.

The primary objective of this study is to evaluate the volume (percentage) of CM saved over the total procedure, during manual injection.

The secondary objective of this study is to evaluate image quality.

Clinical Study Identifier: TX208022

Find a site near you

Start Over

Baptist Health Lexington Clinical Research Center

1740 Nicholasville Road Lexington, KY USA
  Connect »